- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-678/19: Judgment of the General Court of 16 June 2021 — Health Product Group v EUIPO — Bioline Pharmaceutical (Enterosgel) (EU trade mark — Invalidity proceedings — International registration designating the European Union — Figurative mark Enterosgel — No bad faith — Article 51(1)(b) of Regulation (EC) No 40/94 (now Article 59(1)(b) of Regulation (EU) 2017/1001))
ECLI:EU:UNKNOWN:62019TA0678
62019TA0678
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
Official Journal of the European Union
C 310/22
(Case T-678/19) (*)
(EU trade mark - Invalidity proceedings - International registration designating the European Union - Figurative mark Enterosgel - No bad faith - Article 51(1)(b) of Regulation (EC) No 40/94 (now Article 59(1)(b) of Regulation (EU) 2017/1001))
(2021/C 310/26)
Language of the case: English
Parties
Applicant: Health Product Group sp. z o.o. (Warsaw, Poland) (represented by: M. Kondrat, M. Stępień and A. Przytuła, lawyers)
Defendant: European Union Intellectual Property Office (represented by: E. Markakis and V. Ruzek, acting as Agents)
Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Bioline Pharmaceutical AG (Baar, Switzerland) (represented by: T. Grucelski, H. Gajek and M. Furmańska, lawyers)
Re:
Action brought against the decision of the Fourth Board of Appeal of EUIPO of 8 August 2019 (Case R 482/2018-4), relating to invalidity proceedings between Health Product Group and Bioline Pharmaceutical.
Operative part of the judgment
The Court:
1.Dismisses the action;
2.Orders Health Product Group sp. z o.o. to pay the costs.
(*) Language of the case: English.
(1) OJ C 399, 25.11.2019.